Volltext verfügbar nach Anmeldung bzw. im Campus-Netz.
Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP
In: Business Wire (English), 2024-05-02
Online
Zeitungsartikel
Zugriff:
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its reference materials for adeno associated virus (AAV) and lentiviral vector (LVV) portfolio, designed to streamline Cell and Gene Therapy (CGT) research and development as it scales to Good Manufacturing Practice- (GMP) quality. [ABSTRACT FROM PUBLISHER]
Titel: |
Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP
|
---|---|
Autor/in / Beteiligte Person: | Charles River Laboratories International, Inc. |
Zeitschrift: | Business Wire (English), 2024-05-02 |
Veröffentlichung: | 2024 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|